文献速递儿科影像技术与安全CT

基于治疗前增强CT影像组学预测儿童淋巴瘤化疗反应:一项假设生成研究

Predicting chemotherapy response in pediatric lymphoma using pre-treatment contrast-enhanced CT radiomics: A hypothesis-generating study.
PubMed 文献 · Abdom Radiol (NY) · 2025-11-18

该回顾性研究纳入92例儿童淋巴瘤患者,从治疗前静脉期增强CT提取960个影像组学特征,构建逻辑回归模型预测化疗反应。训练集AUC为0.883(95%CI 0.799-0.967),测试集AUC为0.809(95%CI 0.606-1.000),10次重复随机划分中训练集平均AUC为0.915、测试集为0.767。

要点

  • 治疗前静脉期增强CT影像组学模型在测试集预测化疗反应的AUC为0.809(95%CI 0.606-1.000)。
  • 最终模型纳入8个影像组学特征,包括4个滤波变换一阶特征和4个滤波变换纹理特征。
  • 10次重复随机划分中测试集平均AUC为0.767,提示模型稳健性有待进一步验证。

核心结论

  • 这项假设生成研究表明,基线增强CT影像组学在预测儿童淋巴瘤化疗反应方面显示出前景。

研究设计与样本

  • 回顾性研究,纳入92例儿童淋巴瘤患者(72例男性、20例女性),按治疗结局分为反应组74例和无反应组18例,随机分层为训练集65例(70%)和测试集27例(30%),从目标病灶静脉期基线增强CT提取960个影像组学特征,采用SMOTE构建逻辑回归分类模型,并在10次独立随机训练-测试划分中重复整个影像组学流程。

诊断标准与关键数值

  • SMOTE模型在训练集AUC为0.883(95%CI 0.799-0.967),准确率为0.800。
  • SMOTE模型在测试集AUC为0.809(95%CI 0.606-1.000),准确率为0.741。
  • 10次重复验证中,SMOTE模型训练集平均AUC为0.915,测试集平均AUC为0.767。

临床应用与阅片要点

  • 作者认为基线增强CT影像组学可能有助于预测儿童淋巴瘤的化疗反应,但本研究为假设生成性质。

局限性

  • 原文结论将本研究定位为假设生成研究(hypothesis-generating study)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To preliminarily evaluate the predictive value of baseline contrast-enhanced CT (CECT) radiomics for assessing chemotherapy response in pediatric lymphoma.

METHODS: This retrospective study included 92 pediatric patients with lymphoma (72 males, 20 females). Patients were classified as responders (n = 74) and non-responders (n = 18) based on treatment outcomes. The cohort was randomly stratified into a training set (n = 65, 70%) and a test set (n = 27, 30%). A total of 960 radiomics features were extracted from venous-phase baseline CECT images of target lesions. Feature selection was performed, and a logistic regression model was developed for response classification using the Synthetic Minority Over-sampling Technique (SMOTE). To evaluate model robustness, the entire radiomics pipeline was repeated across 10 independent randomized train-test splits. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, reporting the area under the ROC curve (AUC), 95% confidence intervals (CIs), and accuracy.

RESULTS: Eight radiomics features were selected for the final model, including four filter-transformed first-order features and four filter-transformed texture features. The SMOTE model achieved an AUC of 0.883 (95% CI: 0.799-0.967) and an accuracy of 0.800 in the training set. In the test set, the SMOTE model achieved an AUC of 0.809 (95% CI: 0.606-1.000) and an accuracy of 0.741. In repeated validation, the SMOTE model showed mean AUCs of 0.915 (training) and 0.767 (test) across 10 splits.

CONCLUSION: This hypothesis-generating study demonstrates that baseline CECT radiomics shows promise for predicting chemotherapy response in pediatric lymphoma.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Tong Y, Wang H, Zhang X, et al. Predicting chemotherapy response in pediatric lymphoma using pre-treatment contrast-enhanced CT radiomics: A hypothesis-generating study. Abdom Radiol (NY). 2025. PMID: 41251736. doi:10.1007/s00261-025-05283-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。